Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Yue Jin, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yao Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2023-184701

Published: 2023

Journal Articles

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Blood (2023) 142 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2023-184415

Published: 2023

Journal Articles

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

Chen Zhao, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 7012.

https://doi.org/10.1182/blood-2023-184639

Published: 2023

Journal Articles

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Shuang Fan, Hao-Yang Hong, Xin-Yu Dong, Lan-Ping Xu, Xiao-hui Zhang, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Fengrong Wang, Jing-Zhi Wang, Kaiyan Liu, Meng-Zhu Shen, Xiao-jun Huang, Shen-Da Hong, Xiao-Dong Mo

Blood (2022) 140 (Supplement 1): 7691–7692.

https://doi.org/10.1182/blood-2022-165067

Published: 2022

Journal Articles

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Blood (2022) 140 (Supplement 1): 4770–4771.

https://doi.org/10.1182/blood-2022-166307

Published: 2022

Journal Articles

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Haixia Fu, Meng Lv, Yuanyuan Zhang, Tingting Han, Xiao-Dong Mo, Fengrong Wang, Chenhua Yan, Jun Kong, Yu Wang, Yuqian Sun, Wei Han, Huan Chen, Yao Chen, Yu-Hong Chen, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 4705–4706.

https://doi.org/10.1182/blood-2022-166920

Published: 2022

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Development and Validation of a Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Aobei Zhang, Haixia Fu, Yuanyuan Zhang, Kaiyan Liu, Yu Wang, Xiao-Dong Mo, Wei Han, Tingting Han, Huan Chen, Yao Chen, Yuqian Sun, Xiaojun Huang, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 1893–1894.

https://doi.org/10.1182/blood-2022-166364

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

Harnessing Extracellular Vesicles from Red Blood Cells for Targeted Delivery of Therapeutic Peptides and RNAs for Leukemia Treatment

Migara Kavishka Jayasinghe, Marco Pirisinu, Huan Chen, Yuqi Yang, Boya Peng, Jiahai Shi, Minh TN Le

Blood (2021) 138 (Supplement 1): 3980.

https://doi.org/10.1182/blood-2021-147611

Published: 2021

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Siqi Li, Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Huan Chen, Yu-Hong Chen, Fengrong Wang, Wei Han, Yuqian Sun, Chenhua Yan, Meng Lyu, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Yingjun Chang, Xiao Jun Huang

Blood (2021) 138 (Supplement 1): 517.

https://doi.org/10.1182/blood-2021-150011

Published: 2021

Journal Articles

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Ning Ma, Lan-Ping Xu, Xiaohui Zhang, Yu Wang, Huan Chen, Wei Han, Yuqian Sun, Chenhua Yan, Fei-Fei Tang, Xiaodong Mo, Yan-Rong Liu, Kaiyan Liu, Xiao Jun Huang, Ying-Jun Chang

Blood (2021) 138 (Supplement 1): 2880.

https://doi.org/10.1182/blood-2021-149088

Published: 2021

Journal Articles

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Blood (2021) 138 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2021-150437

Published: 2021

Journal Articles

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138408

Published: 2020

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 2049.

https://doi.org/10.1182/blood-2019-127704

Published: 2019

Journal Articles

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chenhua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiao-Dong Mo, MD, Xiang-Yu Zhao, Kai-yan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 5622.

https://doi.org/10.1182/blood-2019-129781

Published: 2019

Journal Articles

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Xiaodong Mo, Xiaohui Zhang, MD, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Sining Liu, Kaiyan Liu, Xiaojun Huang

Blood (2019) 134 (Supplement_1): 5716.

https://doi.org/10.1182/blood-2019-124371

Published: 2019

Journal Articles

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 3261.

https://doi.org/10.1182/blood-2019-126230

Published: 2019

Journal Articles

Haplo-SCT Mediates Stronger GVL Effect Than HLA-Matched Sibling Allograft By Significantly Reducing Leukemia Burden

Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Huan Chen, Chen-Hua Yan, Kaiyan Liu, MD PhD, Xiao-Jun Huang

Blood (2018) 132 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2018-99-118409

Published: 2018

NARROW

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Development and Validation of a Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Harnessing Extracellular Vesicles from Red Blood Cells for Targeted Delivery of Therapeutic Peptides and RNAs for Leukemia Treatment

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Haplo-SCT Mediates Stronger GVL Effect Than HLA-Matched Sibling Allograft By Significantly Reducing Leukemia Burden

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only